Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,993,745
-$431,734 QoQ
Shares Held
124,325
+1.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#797
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Investment Advisors LLC holds $29,370,058 across 10 Drug Manufacturers - General names. PFE ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,242 | $12,284,562 | |
| 2 | JNJ |
Johnson & Johnson
|
24,730 | $6,280,678 | |
| 3 | AMGN |
Amgen Inc
|
12,195 | $4,416,052 | |
| 4 | PFE |
Pfizer Inc
This page
|
124,325 | $2,993,745 | |
| 5 | AZN |
Astrazeneca PLC
|
3,602 | $683,011 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,231 | $672,183 | |
| 7 | NVS |
Novartis AG
|
3,555 | $557,139 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,581 | $552,057 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,993,745 | 124,325 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,425,479 | 121,990 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,962,104 | 118,960 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,898,987 | 113,775 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,508,597 | 103,490 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,242,742 | 88,506 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,080,190 | 78,409 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,172,410 | 75,066 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,755,017 | 62,724 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,940,335 | 69,922 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,769,289 | 61,455 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,080,555 | 62,724 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,071,686 | 56,480 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,451,100 | 60,076 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,052,930 | 59,581 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,583,021 | 59,027 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $3,124,513 | 59,594 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,081,971 | 59,532 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,532,016 | 59,814 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,604,900 | 60,565 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,366,086 | 60,421 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,222,275 | 61,338 | Shares | Sole | 2021-08-05 | |
| 2020-12-31 | $2,106,231 | 57,219 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||